Comparative analyses of group 1 vs group 2 based on various patient characteristics. by Nadia Gul (249538)

Subjects:

Parameter estimates of linear mixed effects models for juvenile <i>M</i>. <i>mercenaria</i>, juvenile <i>M</i>. <i>arenaria</i> and juvenile <i>A</i>. <i>islandica</i> mean shell c... by Teagan McMahon (20108036)

Subjects:

Average experimental conditions (± standard deviation) for each tank. by Teagan McMahon (20108036)

Subjects:

Visual examples of the change in maximum height measure. by Teagan McMahon (20108036)

Subjects:

Frequency of hypoglycemic episodes in group 1 vs group 2. by Nadia Gul (249538)

Subjects:

Demographics and baseline characteristics of patients. by Nadia Gul (249538)

Subjects:

Parameter estimates from the final models for <i>M</i>. <i>mercenaria</i> & <i>M</i>. <i>arenaria</i> mortality. by Teagan McMahon (20108036)

Subjects:

Impact of group 1 and group 2 drugs on hyperglycemia based on HbA1c levels before and after 3 months of administration. by Nadia Gul (249538)

Subjects:

Correlations between perceptual bias scores, age, and autism-associated features: Simple linear regression showing a significant correlation between elevated proprioceptive bias an... by Daniel E. Lidstone (21567523)

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Flow diagram of the patient selection into the final analysis. by Zi-Rong Chen (9227618)

Subjects:

Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

Subjects:

Associations between demographic variables, In4_SED and SE changes at 6 and 12 months after 4_SED (<i><i>n</i></i> = 80). by Zi-Rong Chen (9227618)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

Flow Chart of Study Participant Selection. by Zhi Jin (3742471)

“…Notably, individuals with long sleep duration (>9 hours) had a significantly decreased risk of CVD (OR: 0.36, 95% CI: 0.15–0.85, P = 0.02) compared to those with shorter sleep durations.…”

Thioflavin-T (ThT) fluorescence analysis of amyloid fibril formation in wild-type and p.R163C mutant αB-crystallin under thermochemical stress. by Aref Baharvand (21713886)

Study Data. by Jonathan S. Jahr (2709088)

“…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”

Study outcomes. by Jonathan S. Jahr (2709088)

“…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”

Patient characteristics. by Jonathan S. Jahr (2709088)

“…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”

Image 12_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)